Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2023 08:00 ET | Source: CytoReason

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease modeling, today announced an expansion of its collaboration with Sanofi. The multiyear...
September 20, 2022 08:00 ET | Source: CytoReason

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development

TEL AVIV, Israel, Sept. 20, 2022 (GLOBE NEWSWIRE) -- CytoReason today announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence technology for...